MARKETSnap
  • Gainers &
    Losers
  • Most Active &
    More
  • 52-Week
    High/Low
  • P/E
    Ratios
    • Large Caps
    • Absolute
    • Total Market PE
  • Stocks
    Performance
    • Large Caps
    • Absolute
  • Industries
    Performance
    • Industry
    • Sector
  • Dividends
  • 📅 Calendar
    • Earnings Calendar
    • Dividends Calendar
    • Economics Calendar
  • 🔧 Tools
    • 💰 Intrinsic Value Calculator
    • 📈 Compounding Calculator
    • 🤖 Stock Pick Screener
  • More
    • Charts
    • Investment Compounding Calculator
    • Commodities
    • Currencies
    • Economic Indicators
      • Inflation
      • Consumer Sentiment
      • Recession Probability
      • Treasury Rates
      • GDP
NNOX stock logo

NNOX

Nano-X Imaging Ltd.

$0.88
0
 (0.06%)
Exchange:  NASDAQ
Market Cap:  60.991M
Shares Outstanding:  35.654M
Delayed data
Calculate NNOX Intrinsic Value
5-year outlook →
Overview
Earnings
Financials
Valuation
Chart

About The Company

Sector:  Healthcare
Industry:  Medical – Devices
   
CEO:  Erez I. Meltzer
Full Time Employees:  197
Address: 
Communications Center
Neve Ilan
9.085M
IL
Website:  https://www.nanox.vision
Nano-X Imaging Ltd. specializes in developing a commercial-grade tomographic imaging device that incorporates an innovative digital X-ray source, which leverages a digital micro-electro-mechanical systems (MEMS) semiconductor cathode. Beyond its hardware focus, the company also delivers teleradiology services and creates artificial intelligence (AI) applications tailored for practical use in medical imaging. Its core offerings include the Nanox.ARC, a prototype medical imaging system that integrates its proprietary digital X-ray technology, and Nanox.CLOUD, a complementary cloud-based software platform envisioned to facilitate medical screening as a service. Nano-X also operates Nanox.MARKETPLACE, a platform designed to connect imaging facilities and customers with radiologists for efficient remote interpretation of medical scans. Additionally, the company provides AI-driven software solutions to a wide range of healthcare entities, including hospitals, health maintenance organizations, integrated delivery networks, pharmaceutical companies, and insurers. These solutions are designed to analyze data from existing computed tomography (CT) scans to identify or predict undiagnosed or underdiagnosed medical conditions, such as osteoporosis and cardiovascular disease. Nano-X further offers Teleradiology Services, delivering remote imaging interpretation to radiology practices, hospitals, medical clinics, diagnostic imaging centers, urgent care facilities, and multi-specialty physician groups. Founded in 2011, Nano-X Imaging Ltd. is headquartered in Neve Ilan, Israel.

Click to read more…

Revenue Segmentation

🔒 You are currently logged out

Login

It’s free

EPS

Historical EPS and analyst estimates in one chart. Log in for the full interactive view and links to detailed estimates.

Log in to continue

Log in for the full EPS chart and links to analyst estimates.

Login — it's free
View full analyst estimates

Earnings Call

Full text

Earnings transcript

Read the complete earnings call transcript.

AI summary

Key takeaways

Short, structured highlights from the call so you can focus on what matters.

2026/06/25 — Q1 quarter 2026

Log in to continue

Log in to read the full transcript and AI-generated earnings summaries.

Login — it's free
Income Statement
Balance Sheet
Cash Flow Statement
Analyst Estimates

Income Statement

Year202320242025
Revenue9,90511,28313,021
Gross Profit-6,592-10,609-12,788
EBITDA-47,693-45,013-49,002
Operating Income-62,589-56,746-60,699
Net Income-60,776-53,516-75,018

Log in to continue

Log in to see the income statement and 10 historical years.

Login — it's free

(* All numbers are in thousands)

Balance Sheet

Year202320242025
Total Assets218,648210,002162,165
Total Liabilities23,13420,8830
Total Stockholders Equity195,514189,119139,732
Total Debt8,3967,4464,086
Cash and Cash Equivalents56,37739,30449,151

Log in to continue

Log in to see the balance sheet and 10 historical years.

Login — it's free

(* All numbers are in thousands)

Cash Flow Statement

Year202320242025
Operating Cash Flow-44,777-36,598-40,793
Capital Expenditure-3,303-2,767-4,207
Free Cash Flow-48,080-39,365-45,000
Net Income-60,776-53,516-75,018
Net Change in Cash17,848-17,0739,847

Log in to continue

Log in to see the cash flow statement and 10 historical years.

Login — it's free

(* All numbers are in thousands)

Analyst Estimates

Fiscal Year2030Research AccessResearch AccessResearch AccessResearch Access
Estimated Revenue (Low)176,840.073Research AccessResearch AccessResearch AccessResearch Access
Estimated Revenue (High)209,939.235Research AccessResearch AccessResearch AccessResearch Access
Estimated Revenue (Avg)192,533Research AccessResearch AccessResearch AccessResearch Access
Estimated Ebitda (Low)-209,939.235Research AccessResearch AccessResearch AccessResearch Access
Estimated Ebitda (High)-176,840.073Research AccessResearch AccessResearch AccessResearch Access
Estimated Ebitda (Avg)-192,533Research AccessResearch AccessResearch AccessResearch Access
Estimated Net Income (Low)19,114.993Research AccessResearch AccessResearch AccessResearch Access
Estimated Net Income (High)23,893.256Research AccessResearch AccessResearch AccessResearch Access
Estimated Net Income (Avg)21,380.700Research AccessResearch AccessResearch AccessResearch Access
Estimated SGA Expense (Low)1,576,001.325Research AccessResearch AccessResearch AccessResearch Access
Estimated SGA Expense (High)1,870,981.542Research AccessResearch AccessResearch AccessResearch Access
Estimated SGA Expense (Avg)1,715,856.921Research AccessResearch AccessResearch AccessResearch Access
Estimated EPS (Avg)0.330Research AccessResearch AccessResearch AccessResearch Access
Estimated EPS (High)0.370Research AccessResearch AccessResearch AccessResearch Access
Estimated EPS (Low)0.300Research AccessResearch AccessResearch AccessResearch Access
Number of Analysts (Estimated Revenue)1Research AccessResearch AccessResearch AccessResearch Access
Number of Analysts (Estimated EPS)1Research AccessResearch AccessResearch AccessResearch Access

Log in to continue

Log in and subscribe to Full Access to see up to 5 years of analyst estimates.

Login — it's free

(* All numbers are in thousands)

Current Key Metrics

?Revenue
 (TTM)
: 
9.905M  ?P/S
 (TTM)
: 
4.12
?Net Income
 (TTM)
: 
-60776000  ?P/E
 (TTM)
: 
-0.75
?Enterprise Value
 (TTM)
: 
23.632M  ?EV/FCF
 (TTM)
: 
-0.46
?Dividend Yield
 (TTM)
: 
0%  ?Payout Ratio
 (TTM)
: 
0%
?ROE
 (TTM)
: 
-51.88%  ?ROIC
 (TTM)
: 
-44.34%
?Net Debt
 (TTM)
: 
-48948000  ?Debt/Equity
 (TTM)
: 
0.06
?P/B
 (TTM)
: 
0.47  ?Current Ratio
 (TTM)
: 
3.64

Log in to continue

Log in to see all key valuation metrics and ratios for this symbol.

Login — it's free

Forward P/E Ratios

?

Forward P/E (Avg EPS estimate) — log in with Research Access for high/low estimates and the interactive table.

Forward P/E 1YResearch AccessResearch AccessResearch AccessResearch Access
N/AResearch AccessResearch AccessResearch AccessResearch Access

Log in to continue

Log in with Full Access for forward P/E high/low estimates and the full multi-year table.

Login — it's free

SWOT Analysis

Strengths (preview)

  • Innovative Technology Focus: Nano-X Imaging Ltd. is positioned in the medical imaging industry with a focus on developing cost-effective and accessible X-ray technology, as highlighted in the company profile description. This innovative approach differentiates NNOX from traditional imaging providers and could drive long-term growth.
  • Strong Cash Position: Balance sheet data indicates a robust level of cash and cash equivalents relative to total current liabilities, providing financial flexibility for R&D and operational scaling without immediate liquidity concerns.
  • Market Cap and Sector Positioning: With a notable market capitalization as per company profile metrics, NNOX holds a competitive stance within the healthcare sector, potentially attracting institutional investors seeking exposure to medical technology innovations.

Log in with Research Access for Weaknesses, Opportunities, Threats, and the complete SWOT.

Log in to continue

Log in with Full Access for the complete SWOT analysis.

Login — it's free

At what price to buy it? -
Intrinsic Value Calculator

This is an automatic estimate. The most reliable way to know fair value for your own assumptions is to run the calculator below.

[intrinsic_calculator]

Common questions about NNOX valuation

Is Nano-X Imaging Ltd. (NNOX) overvalued or undervalued right now?

MARKETSnap estimates intrinsic value for Nano-X Imaging Ltd. (NNOX) using its proprietary valuation methodology, which incorporates discounted cash flow (DCF) analysis together with long-term earnings and fundamentals assumptions. By comparing intrinsic value to the current market price, long-term investors can see whether the stock screens as potentially overvalued, fairly valued, or undervalued today.

Is NNOX a buy, hold, or sell for long-term investors?

MARKETSnap does not give one-word “buy” or “sell” calls. Instead, it shows whether NNOX trades at a premium or discount to its estimated intrinsic value, how sensitive that value is to growth and margin assumptions, and how the stock fits into a diversified, long-term portfolio so investors can make their own buy, hold, or sell decision.

What is NNOX’s P/E ratio?

You can see NNOX’s trailing P/E (TTM) and forward P/E estimates in the Current Key Metrics and Forward P/E Ratios sections above. The P/E ratio compares the current share price to earnings per share and helps investors gauge valuation relative to earnings.

How is intrinsic value calculated for NNOX?

MARKETSnap uses its own valuation framework—not a generic spreadsheet DCF alone. Future cash flows and earnings are projected, discounted, and combined with MARKETSnap’s methodology so intrinsic value reflects fundamentals and long-term assumptions. You can run your own inputs and see the result using the Intrinsic Value Calculator above.

Is NNOX a good long-term investment?

Whether NNOX fits a long-term portfolio depends on your assumptions about growth, margins, and risk. MARKETSnap provides the metrics, intrinsic value calculator, and SWOT context so you can form your own view rather than rely on a single buy/sell rating.

NNOX

1-day price chart preview. Log in for 1W through 5Y ranges and period tabs.

Daily snapshot

0.06
MARKETSnap

Trading Metrics:

Open: 0.87   Previous Close: 0.88
Day Low: 0.86   Day High: 0.89
Year Low: 0.73   Year High: 4.71
Price Avg 50: 1.11   Price Avg 200: 2.22
Volume: 324922   Average Volume: 2.044M

Log in to continue

Log in for multi-period charts (1W–5Y), period tabs, and the same layout as members.

Login — it's free

NNOX full analysis

01/12/2025

Welcome to MARKETSNAP’s SWOT analysis for Nano-X Imaging Ltd, also known by its ticker NNOX. If you’re not familiar with this company, let me give you the quick rundown. Nano-X Imaging is a player in the medical imaging technology space, operating within the healthcare sector. They’re focused on developing innovative, cost-effective X-ray imaging systems, aiming to make medical diagnostics more accessible worldwide. It’s a niche but potentially game-changing field, and today we’re diving deep into what makes this company tick,…

Open MarketSnap Listen

Log in to continue

Log in to see the full analysis preview and audio links.

Login — it's free

See in Nexus

Relevant news

NNOX Shareholder Alert: Nano-X Imaging Ltd. Securities Class Action Lawsuit - Investors With Losses May Contact The Gross Law Firm
23-06-2026 10:02
NNOX Shareholder Alert: Nano-X Imaging Ltd. Securities Class Action Lawsuit - Investors With Losses May Contact The Gross Law Firm
CLASS ACTION DEADLINE TONIGHT: Faruqi & Faruqi, LLP Reminds Nano-X Imaging (NNOX) Investors of Securities Class Action Lawsuit Deadline on August 11, 2026
11-08-2026 09:18
CLASS ACTION DEADLINE TONIGHT: Faruqi & Faruqi, LLP Reminds Nano-X Imaging (NNOX) Investors of Securities Class Action Lawsuit Deadline on August 11, 2026
NNOX EQUITY ACTION NOTICE: Faruqi & Faruqi, LLP Reminds Nano-X Imaging (NNOX) Investors of Securities Class Action Lawsuit Deadline on August 11, 2026
10-08-2026 10:10
NNOX EQUITY ACTION NOTICE: Faruqi & Faruqi, LLP Reminds Nano-X Imaging (NNOX) Investors of Securities Class Action Lawsuit Deadline on August 11, 2026
NANO-X DEADLINE: ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Nano-X Imaging Ltd. Investors with Losses in Excess of $100K to Secure Counsel Before Important August 11 Deadline in Securities Class Acti
07-08-2026 13:55
NANO-X DEADLINE: ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Nano-X Imaging Ltd. Investors with Losses in Excess of $100K to Secure Counsel Before Important August 11 Deadline in Securities Class Acti
NNOX Shareholder Alert: August 11, 2026 Lead Plaintiff Deadline in Nano-X Imaging Ltd. Securities Class Action - Contact The Gross Law Firm
07-08-2026 10:17
NNOX Shareholder Alert: August 11, 2026 Lead Plaintiff Deadline in Nano-X Imaging Ltd. Securities Class Action - Contact The Gross Law Firm
NNOX DEADLINE NOTICE: ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Nano-X Imaging Ltd. Investors with Losses in Excess of $100K to Secure Counsel Before Important August 11 Deadline in Securities Class
06-08-2026 22:10
NNOX DEADLINE NOTICE: ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Nano-X Imaging Ltd. Investors with Losses in Excess of $100K to Secure Counsel Before Important August 11 Deadline in Securities Class

DISCLAIMER: The stock market data provided on this website is for informational purposes only and is not intended for trading purposes. While we strive to provide accurate and timely information, we cannot guarantee that the information is accurate at the moment it is received or that it will continue to be accurate in the future. We are not responsible for any actions taken based on the information provided on this website. Always consult with a licensed financial professional before making any investment decisions.
Terms of Service

Copyright © 2025 MarketSnap. All rights reserved.

Contact Us

Privacy Policy

Cookie Policy

Terms of Service

Hover Image
MARKETSnap

Market

🇺🇸 United States

Language

    • Gainers & Losers
    • Most Active & More
    • 52-Week High/Low
    • Dividends
      • Large Caps
      • Absolute
      • Total Market PE
      • Large Caps
      • Absolute
      • Industry
      • Sector
  • 💰 Stock intrinsic value Calculator
  • 📈 Investment Compounding Calculator
  • 🤖 Stock Pick Screener
  • 📋 Watchlist & Portfolio
    • Earnings Calendar
    • Dividends Calendar
    • Economics Calendar
    • Commodities
    • Currencies
      • Inflation
      • Consumer Sentiment
      • Recession Probability
      • Treasury Rates
      • GDP
  • Philosophy
  • Nexus
  • Login Login
  • Profile Profile
  • Watchlist & Portfolio Watchlist & Portfolio
  • My Valuations My Valuations
  • Settings Settings

Media

Watch Listen Read